← Back to Search

Diagnostic Test

Xpert MRSA/SA SSTI for Skin Abscess

N/A
Waitlist Available
Led By Larissa S May, MD
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* adults 18 years or older with community onset abscess
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This study expands upon pilot data for feasibility since May 2011. The study aims to evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in real-time on patient management decisions regarding the use of antimicrobial agents. Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus standard culture.

Eligible Conditions
  • Skin Abscess

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With Antibiotic Usage at the Time of the ED Visit
Secondary study objectives
Clinical Outcome at One or Three Months
Participant Clinical Improvement Post-treatment at One Week

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Xpert MRSA/SA SSTIExperimental Treatment1 Intervention
use of the Xpert MRSA/SSTI diagnostic assay
Group II: Standard cultureActive Control1 Intervention
performance of standard bacterial culture of abscess material
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Xpert MRSA/SA SSTI
2011
N/A
~260

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor
254 Previous Clinical Trials
466,343 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,328 Previous Clinical Trials
14,874,373 Total Patients Enrolled
Larissa S May, MDPrincipal InvestigatorThe George Washington University
1 Previous Clinical Trials
200 Total Patients Enrolled
~17 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top